The effect of miR-106b and miR-93 on cell migration, invasion and proliferation of breast cancer was reversed by the alternation of PTEN expression, suggesting that PTEN was the downstream target to mediate the effect of miR-106b and miR-93. The gene discussed is PTEN; the disease is breast carcinoma.